Literature DB >> 16481627

Assessment of cystic fibrosis transmembrane conductance regulator (CFTR) activity in CFTR-null mice after bone marrow transplantation.

Emanuela M Bruscia1, Joanna E Price, Ee-Chun Cheng, Scott Weiner, Christina Caputo, Elisa C Ferreira, Marie E Egan, Diane S Krause.   

Abstract

Several studies have demonstrated that bone marrow (BM)-derived cells give rise to rare epithelial cells in the gastrointestinal (GI) and respiratory tracts after BM transplantation into myeloablated recipients. We investigate whether, after transplantation of cystic fibrosis transmembrane conductance regulator (CFTR)-positive BM-derived cells, BM-derived GI and airway epithelial cells can provide CFTR activity in the GI tract and nasal epithelium of recipient cystic fibrosis mice. CFTR-/- mice were transplanted with wild-type BM after receiving different doses of irradiation, and CFTR activity was assessed in vivo in individual mice over time by using rectal and nasal potential difference analyses and in vitro by Ussing chamber analysis. The data suggest that rare BM-derived epithelial cells in the GI and nasal epithelium detected in CFTR-/- transplanted mice provide a modest level of CFTR-dependent chloride secretion. Detection of CFTR mRNA and protein in tissues of transplanted CFTR-/- mice supports these data.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16481627      PMCID: PMC1413802          DOI: 10.1073/pnas.0510758103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Electrophysiological approach to studying CFTR.

Authors:  Horst Fischer
Journal:  Methods Mol Med       Date:  2002

2.  Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.

Authors:  Tonghui Ma; Jay R Thiagarajah; Hong Yang; Nitin D Sonawane; Chiara Folli; Luis J V Galietta; A S Verkman
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 3.  Tissue injury in marrow transdifferentiation.

Authors:  M Abedi; D A Greer; G A Colvin; D A Demers; M S Dooner; J A Harpel; J Pimentel; M K Menon; P J Quesenberry
Journal:  Blood Cells Mol Dis       Date:  2004 Jan-Feb       Impact factor: 3.039

4.  Marrow-derived cells as vehicles for delivery of gene therapy to pulmonary epithelium.

Authors:  Joanna E Grove; Carolyn Lutzko; Josef Priller; Octavian Henegariu; Neil D Theise; Donald B Kohn; Diane S Krause
Journal:  Am J Respir Cell Mol Biol       Date:  2002-12       Impact factor: 6.914

Review 5.  Plasticity of marrow-derived stem cells.

Authors:  Erica L Herzog; Li Chai; Diane S Krause
Journal:  Blood       Date:  2003-07-31       Impact factor: 22.113

6.  Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells.

Authors:  Roberto Loi; Travis Beckett; Kaarin K Goncz; Benjamin T Suratt; Daniel J Weiss
Journal:  Am J Respir Crit Care Med       Date:  2005-09-22       Impact factor: 21.405

7.  Radiation pneumonitis in mice: a severe injury model for pneumocyte engraftment from bone marrow.

Authors:  Neil D Theise; Octavian Henegariu; Joanna Grove; Jayishree Jagirdar; Peter N Kao; James M Crawford; Sunil Badve; Romil Saxena; Diane S Krause
Journal:  Exp Hematol       Date:  2002-11       Impact factor: 3.084

8.  Prevention of toxin-induced intestinal ion and fluid secretion by a small-molecule CFTR inhibitor.

Authors:  Jay R Thiagarajah; Talmage Broadbent; Emily Hsieh; Alan S Verkman
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

9.  Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract.

Authors:  Ryuichi Okamoto; Tomoharu Yajima; Motomi Yamazaki; Takanori Kanai; Makio Mukai; Shinichiro Okamoto; Yasuo Ikeda; Toshifumi Hibi; Johji Inazawa; Mamoru Watanabe
Journal:  Nat Med       Date:  2002-08-26       Impact factor: 53.440

10.  Altered channel gating mechanism for CFTR inhibition by a high-affinity thiazolidinone blocker.

Authors:  Alessandro Taddei; Chiara Folli; Olga Zegarra-Moran; Pascale Fanen; A S Verkman; Luis J V Galietta
Journal:  FEBS Lett       Date:  2004-01-30       Impact factor: 4.124

View more
  29 in total

1.  Optimization of targeted cell replacement therapy: a new approach for lung disease.

Authors:  Pascal Duchesneau; Amy P Wong; Thomas K Waddell
Journal:  Mol Ther       Date:  2010-07-20       Impact factor: 11.454

Review 2.  Engraftment of marrow-derived epithelial cells: the role of fusion.

Authors:  Erica L Herzog; Diane S Krause
Journal:  Proc Am Thorac Soc       Date:  2006-11

Review 3.  Stem cells and cell therapies for cystic fibrosis and other lung diseases.

Authors:  Daniel J Weiss
Journal:  Pulm Pharmacol Ther       Date:  2007-12-07       Impact factor: 3.410

Review 4.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Jay K Kolls; Luis A Ortiz; Angela Panoskaltsis-Mortari; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2008-07-15

5.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Ivan Bertoncello; Zea Borok; Carla Kim; Angela Panoskaltsis-Mortari; Susan Reynolds; Mauricio Rojas; Barry Stripp; David Warburton; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2011-06

6.  Partial Restoration of CFTR Function in cftr-Null Mice following Targeted Cell Replacement Therapy.

Authors:  Pascal Duchesneau; Rickvinder Besla; Mathieu F Derouet; Li Guo; Golnaz Karoubi; Amanda Silberberg; Amy P Wong; Thomas K Waddell
Journal:  Mol Ther       Date:  2017-02-08       Impact factor: 11.454

Review 7.  Advances in cell and gene-based therapies for cystic fibrosis lung disease.

Authors:  Mayumi Oakland; Patrick L Sinn; Paul B McCray
Journal:  Mol Ther       Date:  2012-02-28       Impact factor: 11.454

Review 8.  Detection of bone marrow-derived lung epithelial cells.

Authors:  Susannah H Kassmer; Diane S Krause
Journal:  Exp Hematol       Date:  2010-05-04       Impact factor: 3.084

Review 9.  Cftr gene targeting in mouse embryonic stem cells mediated by Small Fragment Homologous Replacement (SFHR).

Authors:  Federica Sangiuolo; Maria Lucia Scaldaferri; Antonio Filareto; Paola Spitalieri; Lorenzo Guerra; Maria Favia; Rosa Caroppo; Ruggiero Mango; Emanuela Bruscia; Dieter C Gruenert; Valeria Casavola; Massimo De Felici; Giuseppe Novelli
Journal:  Front Biosci       Date:  2008-01-01

10.  Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis.

Authors:  Susana Aguilar; Chris J Scotton; Katrina McNulty; Emma Nye; Gordon Stamp; Geoff Laurent; Dominique Bonnet; Sam M Janes
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.